ZA932553B - New use of B-carbolines - Google Patents
New use of B-carbolinesInfo
- Publication number
- ZA932553B ZA932553B ZA932553A ZA932553A ZA932553B ZA 932553 B ZA932553 B ZA 932553B ZA 932553 A ZA932553 A ZA 932553A ZA 932553 A ZA932553 A ZA 932553A ZA 932553 B ZA932553 B ZA 932553B
- Authority
- ZA
- South Africa
- Prior art keywords
- carbolines
- new use
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4212529A DE4212529A1 (en) | 1992-04-10 | 1992-04-10 | Use of µ-carbolines as non-competitive glutamate antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA932553B true ZA932553B (en) | 1993-11-02 |
Family
ID=6456829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA932553A ZA932553B (en) | 1992-04-10 | 1993-04-08 | New use of B-carbolines |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0633779A1 (en) |
| JP (1) | JPH07505404A (en) |
| KR (1) | KR950700739A (en) |
| CA (1) | CA2117755A1 (en) |
| DE (1) | DE4212529A1 (en) |
| FI (1) | FI944714A (en) |
| HU (1) | HUT68212A (en) |
| IL (1) | IL105349A0 (en) |
| WO (1) | WO1993020820A1 (en) |
| ZA (1) | ZA932553B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4330175A1 (en) * | 1993-08-31 | 1995-03-02 | Schering Ag | Alkoxy substituted beta carbolines |
| DE4436190A1 (en) * | 1994-10-10 | 1996-04-11 | Gerhard Prof Dr Bringmann | Halogenated β-carboline derivatives, process for their preparation and use of these substances for inhibiting the respiratory chain |
| RU2106864C1 (en) | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | New approach to treatment of alzheimer's disease |
| US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| AU733880B2 (en) | 1996-09-27 | 2001-05-31 | Eisai Inc. | Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| US20060276477A1 (en) * | 2005-06-06 | 2006-12-07 | Fibrogen, Inc. | Treatment method for anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3540653A1 (en) * | 1985-11-13 | 1987-05-14 | Schering Ag | NEW 3-OXADIAZOLE AND 3-CARBONIC ACID SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
| DE3545776A1 (en) * | 1985-12-20 | 1987-06-25 | Schering Ag | 5-AMINOALKYL-SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
-
1992
- 1992-04-10 DE DE4212529A patent/DE4212529A1/en not_active Withdrawn
-
1993
- 1993-04-06 JP JP5517954A patent/JPH07505404A/en active Pending
- 1993-04-06 EP EP93908924A patent/EP0633779A1/en not_active Withdrawn
- 1993-04-06 WO PCT/EP1993/000858 patent/WO1993020820A1/en not_active Application Discontinuation
- 1993-04-06 CA CA002117755A patent/CA2117755A1/en not_active Abandoned
- 1993-04-06 HU HU9402925A patent/HUT68212A/en unknown
- 1993-04-08 ZA ZA932553A patent/ZA932553B/en unknown
- 1993-04-09 IL IL105349A patent/IL105349A0/en unknown
-
1994
- 1994-10-07 FI FI944714A patent/FI944714A/en not_active Application Discontinuation
- 1994-10-08 KR KR1019940703566A patent/KR950700739A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2117755A1 (en) | 1993-10-11 |
| HUT68212A (en) | 1995-06-28 |
| JPH07505404A (en) | 1995-06-15 |
| HU9402925D0 (en) | 1995-01-30 |
| FI944714A0 (en) | 1994-10-07 |
| EP0633779A1 (en) | 1995-01-18 |
| DE4212529A1 (en) | 1993-10-14 |
| FI944714A (en) | 1994-10-07 |
| KR950700739A (en) | 1995-02-20 |
| IL105349A0 (en) | 1993-08-18 |
| WO1993020820A1 (en) | 1993-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA939367B (en) | Antidepressant and antiperkinsonian compounds | |
| AU118073S (en) | Set of utensils | |
| HU9302059D0 (en) | Differentiating factor of megacaryocyte | |
| IL113248A0 (en) | Use of alpha - 1c specific compounds | |
| HU9402361D0 (en) | New makrolides and use of them | |
| GB9418762D0 (en) | Use of substituted cyclopentane-DI-and-triones | |
| HU9700071D0 (en) | Use of muramilpeptides | |
| ZA932553B (en) | New use of B-carbolines | |
| GB9217820D0 (en) | New use | |
| GB9222985D0 (en) | Use of the tarchonanthus camphoratus | |
| GB9207400D0 (en) | Novel use | |
| EP0522157A4 (en) | Novel use of alkanamidocarboxybetaine | |
| AU119831S (en) | Bathtub | |
| ZA944577B (en) | Preparation of aminopropionitriles | |
| NZ250159A (en) | Use of furan-3-carboxamides as microbicides | |
| GB2275266A8 (en) | Preparation of 2-methyl-3-aminobenzotrifluoride | |
| EP0553954A3 (en) | Preparation of tetramethyldiamino-polyoxyethylenes | |
| HU9401461D0 (en) | New thio-semi-carbazone-thiones | |
| GB9203348D0 (en) | New use of wf13533 substance | |
| ZA944932B (en) | Use of phenalkylamines | |
| GB9224011D0 (en) | New use | |
| GB9218993D0 (en) | New use | |
| GB9216006D0 (en) | New use | |
| GB9220894D0 (en) | New use of the pyrazolopyridine compound | |
| GB9219577D0 (en) | New use of selegiline |